Annual Current Liabilities
$1.44 M
-$1.19 M-45.10%
31 December 2023
Summary:
Titan Pharmaceuticals annual total current liabilities is currently $1.44 million, with the most recent change of -$1.19 million (-45.10%) on 31 December 2023. During the last 3 years, it has fallen by -$1.23 million (-45.90%). TTNP annual current liabilities is now -93.25% below its all-time high of $21.39 million, reached on 31 December 2012.TTNP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$356.00 K
-$203.00 K-36.31%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly total current liabilities is currently $356.00 thousand, with the most recent change of -$203.00 thousand (-36.31%) on 30 June 2024. Over the past year, it has dropped by -$1.09 million (-75.35%). TTNP quarterly current liabilities is now -98.34% below its all-time high of $21.39 million, reached on 31 December 2012.TTNP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -75.3% |
| 3 y3 years | -45.9% | -86.7% |
| 5 y5 years | -59.9% | -90.1% |
TTNP Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -65.8% | at low | -86.7% | at low |
| 5 y | 5 years | -65.8% | at low | -93.9% | at low |
| alltime | all time | -93.3% | at low | -98.3% | at low |
Titan Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $356.00 K(-36.3%) |
| Mar 2024 | - | $559.00 K(-61.3%) |
| Dec 2023 | $1.44 M(-45.1%) | $1.44 M(-22.6%) |
| Sept 2023 | - | $1.87 M(+1.1%) |
| June 2023 | - | $1.85 M(-24.6%) |
| Mar 2023 | - | $2.45 M(-7.0%) |
| Dec 2022 | $2.63 M(-1.5%) | $2.63 M(0.0%) |
| Sept 2022 | - | $2.63 M(+4.2%) |
| June 2022 | - | $2.52 M(+10.8%) |
| Mar 2022 | - | $2.28 M(-14.6%) |
| Dec 2021 | $2.67 M(-36.8%) | $2.67 M(+38.6%) |
| Sept 2021 | - | $1.93 M(-23.5%) |
| June 2021 | - | $2.52 M(-33.0%) |
| Mar 2021 | - | $3.76 M(-11.1%) |
| Dec 2020 | $4.22 M(+17.3%) | $4.22 M(-28.1%) |
| Sept 2020 | - | $5.88 M(+21.0%) |
| June 2020 | - | $4.86 M(+10.1%) |
| Mar 2020 | - | $4.41 M(+22.5%) |
| Dec 2019 | $3.60 M(+4.3%) | $3.60 M(+3.4%) |
| Sept 2019 | - | $3.48 M(-19.8%) |
| June 2019 | - | $4.34 M(-8.8%) |
| Mar 2019 | - | $4.76 M(+37.9%) |
| Dec 2018 | $3.45 M(-22.7%) | $3.45 M(+56.8%) |
| Sept 2018 | - | $2.20 M(-7.8%) |
| June 2018 | - | $2.39 M(-12.1%) |
| Mar 2018 | - | $2.72 M(-39.1%) |
| Dec 2017 | $4.46 M(-8.1%) | $4.46 M(+126.4%) |
| Sept 2017 | - | $1.97 M(+5.5%) |
| June 2017 | - | $1.87 M(-17.7%) |
| Mar 2017 | - | $2.27 M(-53.3%) |
| Dec 2016 | $4.86 M(+0.1%) | $4.86 M(-27.7%) |
| Sept 2016 | - | $6.72 M(+10.7%) |
| June 2016 | - | $6.07 M(+19.4%) |
| Mar 2016 | - | $5.08 M(+4.7%) |
| Dec 2015 | $4.85 M(-27.2%) | $4.85 M(+5.6%) |
| Sept 2015 | - | $4.59 M(-13.1%) |
| June 2015 | - | $5.29 M(-1.0%) |
| Mar 2015 | - | $5.34 M(-19.8%) |
| Dec 2014 | $6.66 M(-38.6%) | $6.66 M(-10.7%) |
| Sept 2014 | - | $7.46 M(-4.6%) |
| June 2014 | - | $7.82 M(-14.6%) |
| Mar 2014 | - | $9.16 M(-15.5%) |
| Dec 2013 | $10.85 M(-49.3%) | $10.85 M(-11.5%) |
| Sept 2013 | - | $12.25 M(-9.4%) |
| June 2013 | - | $13.53 M(-32.3%) |
| Mar 2013 | - | $19.98 M(-6.6%) |
| Dec 2012 | $21.39 M(+317.6%) | $21.39 M(+96.4%) |
| Sept 2012 | - | $10.89 M(+15.1%) |
| June 2012 | - | $9.46 M(+60.8%) |
| Mar 2012 | - | $5.89 M(+14.9%) |
| Dec 2011 | $5.12 M(-5.2%) | $5.12 M(-19.7%) |
| Sept 2011 | - | $6.38 M(+2.8%) |
| June 2011 | - | $6.21 M(-28.8%) |
| Mar 2011 | - | $8.71 M(+61.2%) |
| Dec 2010 | $5.41 M | $5.41 M(+17.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $4.59 M(+91.7%) |
| June 2010 | - | $2.39 M(-58.1%) |
| Mar 2010 | - | $5.71 M(+268.9%) |
| Dec 2009 | $1.55 M(-63.7%) | $1.55 M(-65.1%) |
| Sept 2008 | - | $4.44 M(-8.1%) |
| June 2008 | - | $4.83 M(+9.8%) |
| Mar 2008 | - | $4.40 M(+3.4%) |
| Dec 2007 | $4.26 M(+25.4%) | $4.26 M(+47.6%) |
| Sept 2007 | - | $2.88 M(-11.2%) |
| June 2007 | - | $3.25 M(-1.7%) |
| Mar 2007 | - | $3.30 M(-2.7%) |
| Dec 2006 | $3.39 M(+8.2%) | $3.39 M(-18.0%) |
| Sept 2006 | - | $4.14 M(+38.0%) |
| June 2006 | - | $3.00 M(-6.7%) |
| Mar 2006 | - | $3.21 M(+2.5%) |
| Dec 2005 | $3.14 M(-14.6%) | $3.14 M(-30.1%) |
| Sept 2005 | - | $4.49 M(+30.9%) |
| June 2005 | - | $3.43 M(-23.2%) |
| Mar 2005 | - | $4.47 M(+21.7%) |
| Dec 2004 | $3.67 M(+9.9%) | $3.67 M(+10.5%) |
| Sept 2004 | - | $3.32 M(+26.2%) |
| June 2004 | - | $2.63 M(-36.9%) |
| Mar 2004 | - | $4.17 M(+24.9%) |
| Dec 2003 | $3.34 M(-15.3%) | $3.34 M(-11.7%) |
| Sept 2003 | - | $3.79 M(-5.2%) |
| June 2003 | - | $3.99 M(+1.4%) |
| Mar 2003 | - | $3.94 M(-0.3%) |
| Dec 2002 | $3.94 M(-31.6%) | $3.94 M(+15.4%) |
| Sept 2002 | - | $3.42 M(-9.1%) |
| June 2002 | - | $3.76 M(+8.2%) |
| Mar 2002 | - | $3.47 M(-39.7%) |
| Dec 2001 | $5.76 M(+134.0%) | $5.76 M(+128.7%) |
| Sept 2001 | - | $2.52 M(-13.5%) |
| June 2001 | - | $2.91 M(+11.2%) |
| Mar 2001 | - | $2.62 M(+6.4%) |
| Dec 2000 | $2.46 M(+36.8%) | $2.46 M(-17.2%) |
| Sept 2000 | - | $2.98 M(+88.4%) |
| June 2000 | - | $1.58 M(-28.2%) |
| Mar 2000 | - | $2.20 M(+22.2%) |
| Dec 1999 | $1.80 M(+12.5%) | $1.80 M(+50.0%) |
| Sept 1999 | - | $1.20 M(-25.0%) |
| June 1999 | - | $1.60 M(0.0%) |
| Mar 1999 | - | $1.60 M(0.0%) |
| Dec 1998 | $1.60 M(-5.9%) | $1.60 M(+33.3%) |
| Sept 1998 | - | $1.20 M(+9.1%) |
| June 1998 | - | $1.10 M(-21.4%) |
| Mar 1998 | - | $1.40 M(-17.6%) |
| Dec 1997 | $1.70 M(-32.0%) | $1.70 M(-29.2%) |
| Sept 1997 | - | $2.40 M(-46.7%) |
| June 1997 | - | $4.50 M(-2.2%) |
| Mar 1997 | - | $4.60 M(+84.0%) |
| Dec 1996 | $2.50 M(-66.2%) | $2.50 M(+31.6%) |
| Sept 1996 | - | $1.90 M(-5.0%) |
| June 1996 | - | $2.00 M(-16.7%) |
| Mar 1996 | - | $2.40 M(-67.6%) |
| Dec 1995 | $7.40 M | $7.40 M |
FAQ
- What is Titan Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly current liabilities year-on-year change?
What is Titan Pharmaceuticals annual total current liabilities?
The current annual current liabilities of TTNP is $1.44 M
What is the all time high annual current liabilities for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual total current liabilities is $21.39 M
What is Titan Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of TTNP is $356.00 K
What is the all time high quarterly current liabilities for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly total current liabilities is $21.39 M
What is Titan Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, TTNP quarterly total current liabilities has changed by -$1.09 M (-75.35%)